Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Aid of a Blood Biomarker Panel in Lung Cancer Screening Criteria

Autor: Borg, M., Wen, S., Nederby, L., Hansen, T., Jakobsen, A., Andersen, R., Weinreich, U. M ., Hilberg, O.

Publikováno v: Borg, M, Wen, S, Nederby, L, Hansen, T, Jakobsen, A, Andersen, R, Weinreich, U M & Hilberg, O 2022, ' Aid of a Blood Biomarker Panel in Lung Cancer Screening Criteria ', American Journal of Respiratory and Critical Care Medicine, vol. 205 . https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A2584

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0845b97f432949210f3ddf6fdd06253d
https://vbn.aau.dk/da/publications/c41ec3c7-ac33-4dc7-8f77-ed1184829628

Natural killer cell activity as a prognostic biomarker in non-small cell lung cancer patients treated with check-point inhibitors

Autor: Wen, S. W. C., Hansen, T. S., Nederby, L., Andersen, R. F., Nyhus, C. H., Bertelsen, L., Sorensen, B. T., Hager, H., Hilberg, O., Jakobsen, A., Hansen, T. F.

Publikováno v: Wen, S W C, Hansen, T S, Nederby, L, Andersen, R F, Nyhus, C H, Bertelsen, L, Sorensen, B T, Hager, H, Hilberg, O, Jakobsen, A & Hansen, T F 2020, ' Natural killer cell activity as a prognostic biomarker in non-small cell lung cancer patients treated with check-point inhibitors ', Annals of Oncology, vol. 31, no. Suppl. 4, 1323P, pp. S853 . https://doi.org/10.1016/j.annonc.2020.08.1637

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::a5c88be6e0efb1f4ec5a20bdc9eb9773
https://portal.findresearcher.sdu.dk/da/publications/08786847-a996-42ee-8378-d9314d7d98a0

29P Dynamic NK cell activity as a prognostic biomarker in non-small cell lung cancer treated with curative surgery

Autor: Wen, S.W.C., Nederby, L., Hansen, T.F., Jakobsen, A., Hilberg, O.

Publikováno v: In Annals of Oncology September 2022 33 Supplement 7:S555-S555

1323P Natural killer cell activity as a prognostic biomarker in non-small cell lung cancer patients treated with check-point inhibitors

Autor: Wen, S.W.C., Hansen, T.S., Nederby, L., Andersen, R.F., Nyhus, C.H., Bertelsen, L., Sørensen, B.T., Hager, H., Hilberg, O., Jakobsen, A., Hansen, T.F.

Publikováno v: In Annals of Oncology September 2020 31 Supplement 4:S853-S853